Post-treatment triglyceride-glucose index as survival protective factors in patients with esophageal squamous cell carcinoma

doi:10.5306/wjco.v17.i1.113304

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

(36)

(94)

(0)

(714)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Jan 24, 2026; 17(1): 113304
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113304

Full Size Figure Download Figure

Figure 3 Restricted cubic spline analysis of the association between triglyceride-glucose-related indices and overall survival. A: Pre-treatment triglyceride-glucose (TyG) index; B: Post-treatment TyG index; C: Post-treatment TyG-body weight; D: Post-treatment TyG-body mass index. HR: Hazard ratio; CI: Confidence interval; preTyG: Pre-treatment triglyceride-glucose; postTyG: Post-treatment triglyceride-glucose; postTyG-BW: Post-treatment triglyceride-glucose-body weight; postTyG-BMI: Post-treatment triglyceride-glucose-body mass index.

Citation: Xiao L, Liu YD, Zhang X, Zhang SC, Lyu JH. Post-treatment triglyceride-glucose index as survival protective factors in patients with esophageal squamous cell carcinoma. World J Clin Oncol 2026; 17(1): 113304
URL: https://www.wjgnet.com/2218-4333/full/v17/i1/113304.htm
DOI: https://dx.doi.org/10.5306/wjco.v17.i1.113304

Xiao L, Liu YD, Zhang X, Zhang SC, Lyu JH. Post-treatment triglyceride-glucose index as survival protective factors in patients with esophageal squamous cell carcinoma. World J Clin Oncol 2026; 17(1): 113304 [PMID: 41608344 DOI: 10.5306/wjco.v17.i1.113304]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.